Truist Financial
TTNP

Truist Financial’s Titan Pharmaceuticals TTNP Stock Holding History

Truist Financial’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,255
Closed -$174K – 2730
2024
Q2 		$174K Hold
31,255
– – ﹤0.01% 2539
2024
Q1 		$224K Buy
31,255
+1
+0% +$7 ﹤0.01% 2433
2023
Q4 		$258K Hold
31,254
– – ﹤0.01% 2397
2023
Q3 		$296K Hold
31,254
– – ﹤0.01% 2252
2023
Q2 		$404K Hold
31,254
– – ﹤0.01% 2081
2023
Q1 		$519K Hold
31,254
– – ﹤0.01% 1963
2022
Q4 		$490K Hold
31,254
– – ﹤0.01% 1971
2022
Q3 		$675K Buy
+31,254
New +$807K ﹤0.01% 1666

Other funds holding TTNP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Truist Financial's TTNP Position: Q3 2024 in Review

Truist Financial sold out of Titan Pharmaceuticals (TTNP) in Q3 2024, closing a stake of 31,255 shares — an estimated $174K sold.

Truist Financial first reported a position in TTNP in Q3 2022 and held it in 8 quarters. The position peaked at $675K in Q3 2022. 16 funds tracked by Wall St. Rank hold TTNP as of Q3 2024.

  • Truist Financial reported no remaining Titan Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Truist Financial sold 31,255 Titan Pharmaceuticals shares in Q3 2024, an estimated $174K.
  • Truist Financial first reported a position in Titan Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Truist Financial's Titan Pharmaceuticals position peaked at $675K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q3 2024.

Based on Truist Financial's 13F filing for Q3 2024, filed 13 Nov 2024.